Top compounds associated with response to NDUFB8


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA CID-5951923 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA clofarabine CTRPv2 pan-cancer AAC 0.066 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.03
mRNA canertinib CTRPv2 pan-cancer AAC -0.081 0.03
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.03
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.079 0.03
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA ML083 CTRPv2 pan-cancer AAC -0.085 0.03
Download CSV